TechAlnylam has shown positive results of ‘Vutrisiran’ in patients with ATTR Amyloidosis with Cardiomyopathy by time news September 2, 2024 by time news September 2, 20242024-09-02 12:20:58 Alnylam Pharmaceuticals announced detailed results from the phase 3 HELIOS-B study of vutrisiran, an … Read more 0 FacebookTwitterPinterestEmail